Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermaPro for diabetic foot ulcer wound healing (Phase IIb)
2010-020437-12Phase 2Terminated
- Sponsor
- DermaTools Biotech
- Start
- May 2010
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DermaPro in diabetic foot ulcer (DFU) (2 arms), sponsored by DermaTools Biotech. Primary endpoint: Primary: Reduction of wound area at 30, 60, and 90 days. Started May 2010; status: terminated.
02
Drugs
DermaPro
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2010-020437-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020437-12.